Willis Towers Watson Public Limited Company Q3 FY2025 earnings call

Management Statement and Operational Highlights

• Solid Results: Delivered 5% organic growth, 230 basis points of adjusted operating margin expansion, and adjusted EPS of $3.07.
• Segment Details: Health, Wealth & Career had steady 4% organic growth with margin expansion, driven by solutions for health care costs, pension plans, and regulatory requirements. Risk & Broking had 6% organic growth with margin expansion, driven by specialization strategy and investments in technology.
• New Business Wins: Health, Wealth & Career won global actuarial work for a Fortune 250 company and supported a spin-off. Risk & Broking secured insurance for an energy portfolio and electric vehicle sector.
• WE DO Initiative: Helped improve efficiency with automation and AI, streamlining billing and collections.

Segment Performance

• Health, Wealth & Career: Revenue grew 4% in the third quarter, with 5% organic growth excluding book of business settlement activity and interest income. Health business saw 7% growth (8% excluding book of business settlement activity and interest income), driven by International and North America. Wealth had 5% growth from retirement work. Career grew 2%, with Europe strong due to EU pay transparency support. BD&O grew 2% versus last year's third quarter. Operating margin was 28.6%, an increase of 390 basis points compared to the prior year.
• Risk & Broking: Revenue grew 6%, with Corporate Risk & Broking growing 6% (7% excluding book of business activity and interest income) for the 11th consecutive quarter of high single-digit growth. Operating margin was 18.8%, a 70 basis point improvement over the prior year.

Guidance

• Full Year Objectives: On track for mid-single-digit organic growth, adjusted operating margin expansion, adjusted EPS growth, and free cash flow margin improvement.
• Segment Guidance: Health, Wealth & Career expects mid-single-digit growth and margin expansion. Risk & Broking expects mid- to high single-digit growth despite pricing pressure.
• Free Cash Flow: Generated $838 million for 9 months, expects free cash flow margin expansion. Plan to return $1.5 billion to shareholders via share repurchases and dividends.

Risks

• Macroeconomic Concerns: Global trade, inflation, geopolitical conditions create opportunities and challenges.
• Insurance Market Pressures: Declining rates in commercial insurance segments across geographies.
• Foreign Exchange Impact: Fluctuations in foreign exchange rates affecting financial results.

Question and Answer

Q: On Risk & Broking organic revenue results and unusual wins A: Lucy Clarke discussed new business from specialization strategy and project-based placements.

Q: On free cash flow expectations A: Andrew Krasner mentioned favorable second half setup and divestiture of TRANZACT as tailwinds.

Q: On insurance pricing headwind A: Lucy Clarke noted property class most impacted, but mid- to high single-digit growth expected.

Q: On HWC margins excluding TRANZACT A: Julie Gebauer highlighted portfolio focus, cost structure discipline, and process optimization.

Q: On interest income levels A: Andrew Krasner noted geographic mix impact on interest income.

Q: On war for talent A: Carl Hess and Lucy Clarke discussed strategic hiring and talent retention.

Q: On sensitivity to employment levels A: Julie Gebauer stated no significant softening impact on revenue.

Q: On health business pipeline and share gain A: Carl Hess and Julie Gebauer discussed strong pipeline and demand driven by health care inflation.

Q: On retirement project work and 2026 outlook A: Julie Gebauer discussed core defined benefit, defined contribution, and investments business trends.

Q: On share repurchases and survey-related revenues A: Andrew Krasner discussed $1.5 billion repurchase target and revenue timing impact on expenses.